Enomoto Riyo, Sugahara Chiyoko, Komai Tomoe, Suzuki Chie, Kinoshita Noriko, Hosoda Akiko, Yoshikawa Asa, Tsuda Yuko, Okada Yoshio, Lee Eibai
Department of Pharmacology, Kobe Gakuin University, Ikawadani-cho, Nishi, Kobe 651-2180, Japan.
Biochim Biophys Acta. 2004 Nov 1;1674(3):291-8. doi: 10.1016/j.bbagen.2004.07.004.
We have previously reported that YO-2, a selective plasmin inhibitor, induces thymocyte apoptosis. To elucidate the mechanism of YO-2-induced apoptosis, other YO compounds with different plasmin inhibitory action were tested for the pro-apoptotic activity in this study. The treatment of rat thymocytes with the YO compounds which had the hydrophobic but not the hydrophilic moiety at the C-terminal increased DNA fragmentation, the number of condensed nuclei and caspase-3-like activity. All pro-apoptotic YO compounds not only were potent plasmin inhibitors but also had the hydrophobic C-terminal as the common structure. Therefore, the target molecule of the YO compounds may be located not on the cell surface but rather inside the cells.